Literature DB >> 12645656

Infrequent but high-level amplification of 17p11.2 approximately p12 in human glioma.

Maaike van Dartel1, Sieger Leenstra, Dirk Troost, Theo J M Hulsebos.   

Abstract

We reported previously the amplification of DNA markers in 17p12 in 3 of 60 high-grade gliomas. To detect additional cases, we screened in total 104 gliomas of various types and grades by Southern blot analysis using marker 745R, which is within the commonly amplified region. However, no other caseswith significant amplification (amplification level > 4) were found. To investigate in detail the extent of the amplifications in the three tumors, which were all glioblastomas, we determined 17p11.2 approximately p12 amplification profiles by semiquantitative polymerase chain reaction using 15 microsatellite markers and seven candidate genes. Distinct and high-level amplifications, with maximum levels ranging from 15 to 38, were found in these tumors. The 0.8 Mb-region between D17S1525 and MAP2K4 in 17p12 proved to be commonly amplified in these tumors. In one tumor, a heterogeneous distribution of the amplification in 17p12 was found, suggesting that it is a late event during glioma tumorigenesis. Another tumor showed additional high-level amplification of PMP22 and D17S1843 in 17p11.2. From the high-level amplifications we conclude that at least one, but possibly more, putative oncogenes are present in 17p11.2 approximately p12 whose amplifications and/or overexpressions contribute to glioma tumorigenesis.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12645656     DOI: 10.1016/s0165-4608(02)00683-0

Source DB:  PubMed          Journal:  Cancer Genet Cytogenet        ISSN: 0165-4608


  7 in total

Review 1.  Review of the GAS3 Family of Proteins and their Relevance to Cancer.

Authors:  Negin Ashki; Lynn Gordon; Madhuri Wadehra
Journal:  Crit Rev Oncog       Date:  2015

2.  A gene highly expressed in tumor cells encodes novel structure proteins.

Authors:  Nianli Sang; Donna M Fath; Antonio Giordano
Journal:  Oncogene       Date:  2004-12-16       Impact factor: 9.867

3.  Screening key genes and pathways in glioma based on gene set enrichment analysis and meta-analysis.

Authors:  Yanyan Tang; Wenwu He; Yunfei Wei; Zhanli Qu; Jinming Zeng; Chao Qin
Journal:  J Mol Neurosci       Date:  2013-03-15       Impact factor: 3.444

Review 4.  Genetic aberrations in soft tissue leiomyosarcoma.

Authors:  Jilong Yang; Xiaoling Du; Kexin Chen; Antti Ylipää; Alexander J F Lazar; Jonathan Trent; Dina Lev; Raphael Pollock; Xishan Hao; Kelly Hunt; Wei Zhang
Journal:  Cancer Lett       Date:  2008-07-22       Impact factor: 8.679

5.  Gene expression of PMP22 is an independent prognostic factor for disease-free and overall survival in breast cancer patients.

Authors:  Dan Tong; Georg Heinze; Dietmar Pils; Andrea Wolf; Christian F Singer; Nicole Concin; Gerda Hofstetter; Ingrid Schiebel; Margaretha Rudas; Robert Zeillinger
Journal:  BMC Cancer       Date:  2010-12-15       Impact factor: 4.430

6.  Clinical next generation sequencing of pediatric-type malignancies in adult patients identifies novel somatic aberrations.

Authors:  Jorge Galvez Silva; Fernando F Corrales-Medina; Ossama M Maher; Nizar Tannir; Winston W Huh; Michael E Rytting; Vivek Subbiah
Journal:  Oncoscience       Date:  2015-02-20

7.  Inhibition of protein PMP22 enhances etoposide-induced cell apoptosis by p53 signaling pathway in Gastric Cancer.

Authors:  Jingjing Hou; Lin Wang; Jiabao Zhao; Huiqin Zhuo; Jia Cheng; Xin Chen; Wei Zheng; Zhijun Hong; Jianchun Cai
Journal:  Int J Biol Sci       Date:  2021-07-25       Impact factor: 6.580

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.